Παρακολούθηση
Harish Dureja
Harish Dureja
Professor, Deptt of Pharm. Sci., M. D. University, Rohtak
Η διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα mdu.ac.in
Τίτλος
Παρατίθεται από
Παρατίθεται από
Έτος
Cellular signalling pathways mediating the pathogenesis of chronic inflammatory respiratory diseases: an update
M Mehta, DS Dhanjal, KR Paudel, B Singh, G Gupta, S Rajeshkumar, ...
Inflammopharmacology 28, 795-817, 2020
3252020
Mouth dissolving tablets: A review
D Kaushik, H Dureja, TR Saini
INDIAN DRUGS-BOMBAY- 41 (4), 187-193, 2004
2792004
Cosmeceuticals: An emerging concept
H Dureja, D Kaushik, M Gupta, V Kumar, V Lather
Indian Journal of Pharmacology 37 (3), 155-159, 2005
2532005
Anti‐inflammatory and anticancer activities of Naringenin‐loaded liquid crystalline nanoparticles in vitro
R Wadhwa, KR Paudel, LH Chin, CM Hon, T Madheswaran, G Gupta, ...
Journal of food biochemistry 45 (1), e13572, 2021
2042021
Developments in nutraceuticals
H Dureja, D Kaushik, V Kumar
Indian journal of pharmacology 35 (6), 363-372, 2003
1942003
Microfluidic chips: recent advances, critical strategies in design, applications and future perspectives
P Pattanayak, SK Singh, M Gulati, S Vishwas, B Kapoor, DK Chellappan, ...
Microfluidics and nanofluidics 25, 1-28, 2021
1842021
Evidence of coronavirus (CoV) pathogenesis and emerging pathogen SARS-CoV-2 in the nervous system: a review on neurological impairments and manifestations
NK Jha, S Ojha, SK Jha, H Dureja, SK Singh, SD Shukla, DK Chellappan, ...
Journal of molecular neuroscience, 1-18, 2021
1732021
Simulation of Skin Permeability in Chitosan Membranes
Dureja Harish, Tiwary A. K. and Gupta Sunil
International Journal of Pharmaceutics 213, 193-198, 2001
1342001
Predicting anti-HIV-1 activity of 6-arylbenzonitriles: Computational approach using superaugmented eccentric connectivity topochemical indices
H Dureja, S Gupta, AK Madan
Journal of Molecular Graphics and Modelling 26 (6), 1020-1029, 2008
1032008
Interactions with the macrophages: an emerging targeted approach using novel drug delivery systems in respiratory diseases
M Mehta, N Sharma, M Vyas, N Khurana, PK Maurya, H Singh, ...
Chemico-biological interactions 304, 10-19, 2019
1022019
Current-status and applications of polysaccharides in drug delivery systems
P Prasher, M Sharma, M Mehta, S Satija, AA Aljabali, MM Tambuwala, ...
Colloid and Interface Science Communications 42, 100418, 2021
1012021
Albumin nano-encapsulation of piceatannol enhances its anticancer potential in colon cancer via down regulation of nuclear p65 and HIF-1α
A AA Aljabali, H A. Bakshi, F L. Hakkim, YA Haggag, K M. Al-Batanyeh, ...
Cancers 12 (1), 113, 2020
1012020
Nanoemulsion: A novel drug delivery approach for enhancement of bioavailability
P Pandey, N Gulati, M Makhija, D Purohit, H Dureja
Recent patents on nanotechnology 14 (4), 276-293, 2020
962020
A review of Glycogen Synthase Kinase-3 (GSK3) inhibitors for cancers therapies
R Thapa, G Gupta, AA Bhat, WH Almalki, SI Alzarea, I Kazmi, S Saleem, ...
International journal of biological macromolecules, 127375, 2023
892023
CRISPR/Cas9 gene editing: New hope for Alzheimer's disease therapeutics
S Bhardwaj, KK Kesari, M Rachamalla, S Mani, GM Ashraf, SK Jha, ...
Journal of Advanced Research 40, 207-221, 2022
892022
Superaugmented eccentric connectivity indices: new-generation highly discriminating topological descriptors for QSAR/QSPR modeling
H Dureja, AK Madan
Medicinal Chemistry Research 16, 331-341, 2007
892007
An overview of vaccine development for COVID-19
SH Shahcheraghi, J Ayatollahi, AAA Aljabali, MD Shastri, SD Shukla, ...
Therapeutic delivery 12 (3), 235-244, 2021
872021
Harnessing amphiphilic polymeric micelles for diagnostic and therapeutic applications: Breakthroughs and bottlenecks
J Kaur, V Mishra, SK Singh, M Gulati, B Kapoor, DK Chellappan, G Gupta, ...
Journal of Controlled Release 334, 64-95, 2021
862021
Formulation and evaluation of olanzapine mouth dissolving tablets by effervescent formulation approach
D Kaushik, H Dureja, TR Saini
INDIAN DRUGS-BOMBAY- 41, 410-412, 2004
832004
Targeting neutrophils using novel drug delivery systems in chronic respiratory diseases
DK Chellappan, LW Yee, KY Xuan, K Kunalan, LC Rou, LS Jean, LY Ying, ...
Drug development research 81 (4), 419-436, 2020
772020
Δεν είναι δυνατή η εκτέλεση της ενέργειας από το σύστημα αυτή τη στιγμή. Προσπαθήστε ξανά αργότερα.
Άρθρα 1–20